Parexel

Parexel is among the world’s largest CROs, providing a full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, more than 21,000 professionals work in partnership with biopharmaceutical leaders, innovators and sites to design and deliver clinical trials with patients in mind.

Visit Website

Locations

  • Africa
  • APAC
  • Australia
  • Europe
  • North America
  • South America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • Central Nervous System (CNS)
  • Dental and Oral Health
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Genetic Diseases
  • Hematology
  • Hepatology
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Internal Diseases
  • Metabolic Diseases
  • Musculoskeletal
  • Nephrology
  • Neurology
  • Nutrition and Health
  • Obstetrics / Gynecology
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology/ENT (Ear/Nose/Throat)
  • Pediatrics / Neonatology
  • Pharmacology / Toxicology
  • Podiatry
  • Psychiatry
  • Pulmonary
  • Rare Disease
  • Respiratory
  • Rheumatology
  • Sleep
  • Surgery
  • Thrombosis
  • Urology
  • Vaccines

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart™ every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being named “Best Contract Research Organization” in November 2023 by an independent panel for Citeline, “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey and recipient of the 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships.

Accreditations

Partners are trained on the functionality of the Coder application, process optimization, and scope of Coder services. This Accreditation teaches Partners to integrate the medical coding solution with EDC studies and administer Coder segments. Coder Accreditation is dependent on the successful completion of the Rave EDC accreditation.
Partners are trained on the functionality of the eCOA application, best practices, process optimization and the scope of eCOA services. This Accreditation teaches Partners to process patient data that has been entered by the patient themselves, or by a Clinician. Patients enter their patient data through a provisioned device or their own device after downloading the appropriate app.  Clinicians enter patient data through a provisioned device (Android or iOS). eCOA Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the Safety Gateway application, process optimization, and scope of Safety Gateway services. This Accreditation teaches Partners to utilize the configurable EDC-to-safety-system interface to automate advanced serious adverse event (SAE) collection and E2B transmissions. Safety Gateway Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality of the targeted source document verification (TSDV) application, process optimization, and scope of TSDV services. This Accreditation teaches Partners to implement TSDV in line with regulatory compliance and data quality strategies. TSDV Accreditation is dependent on the successful completion of the Rave EDC Accreditation.
Partners are trained on the functionality and administration of Site Cloud: End of Study content distribution. This includes study and site access provisioning, site content download, and electronic signature acknowledgement. This Accreditation teaches the Partner to administer the electronic distribution and management of study files to sites, including the centralized collection of acknowledgement of receipt documents following delivery.